Current practice of patient follow-up after potentially curative resection of cutaneous melanoma

Plastic and Reconstructive Surgery

Volumn 106, Issue 3, 2000, Pages 590-597

  Virgo, Katherine S ^a,b   Chan, Danny ^a   Handler, Barry S ^a   Johnson, David Y ^a   Goshima, Kaoru ^a   Johnson, Frank E ^a  

^a St Louis University Health Sciences Center ^*

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL PRACTICE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MOTIVATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGEON;

EID: 0033857072     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200009010-00010     Document Type: Article

References (40)

1. Cancer Statistics, 1999
2. Cutaneous malignant melanoma in Norway: Experiences from the Norwegian Melanoma Project
3. Trends in mortality from cutaneous malignant melanoma in Belgium
4. Malignant melanoma of the skin
5. Guidelines for care of malignant melanoma
6. Diagnosis and treatment of early melanoma
7. Cutaneous melanoma
8. Efficacy of an elective regional lymph node dissection of 1 to 4 mm: Thick melanomas for patients 60 years of age and younger
9. Time and frequency of recurrence of cutaneous stage I melanoma with guidelines for follow-up study
10. Malignant melanoma: Evaluation of clinical follow-up by questionnaire survey
11. Late recurrence of localized cutaneous melanoma: Its influence on follow-up policy
12. Multiple primary melanoma: Incidence and risk factors in 283 patients
13. Multiple primary cutaneous melanomas
14. The association between melanoma, lymphoma, and other primary neoplasms
15. Cutaneous melanoma
16. The urgent need to improve health care quality: Institute of Medicine National Roundtable on Health Care Quality
17. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial
18. Intensive diagnostic followup after treatment of primary breast cancer: A randomized trial
19. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas
20. After treatment of early melanoma, should patients and family members be followed? Why and how? NIH Consensus Development Conference Consensus Statement
21. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
22. How tumor stage affects surgeons' surveillance strategies after surgery for carcinoma of the upper aerodigestive tract
23. First recurrence analysis of 840 cutaneous melanomas: A proposal for a follow-up schedule
24. Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians
25. The efficacy of a single posteroanterior radiograph in the assessment of metastatic pulmonary melanoma
26. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma
27. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma
28. 18F-fluorodeoxyglucose positron emission tomography
29. Effectiveness of positron emission tomography for the detection of melanoma metastases
30. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
31. CDKN2A mutations in multiple primary melanomas
32. Follow-up recommendations for patients with stage I malignant melanoma
33. The value of intensive followup after curative resection for colorectal carcinoma
34. Surveillance after colon cancer: Is it worthwhile?
35. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: Does it make sense?
36. Staging evaluation and surveillance for melanoma patients in a fiscally restrictive medical environment: A commentary
37. Current followup strategies after radical prostatectomy: A survey of American Urological Association urologists
38. Clinical surveillance testing after lung cancer operations
39. Systematic reviews: Synthesis of best evidence for clinical decisions